Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ichizawa, N.
Right arrow Articles by Akashi-Tanaka, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichizawa, N.
Right arrow Articles by Akashi-Tanaka, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 32:108-109 (2002)
© 2002 Foundation for Promotion of Cancer Research

Short Communications

Long-term Results of T1a, T1b and T1c Invasive Breast Carcinomas in Japanese Women: Validation of the UICC T1 Subgroup Classification

Natsue Ichizawa, Takashi Fukutomi, Eriko Iwamoto and Sadako Akashi-Tanaka+

Breast Surgery Division, Department of Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan

ABSTRACT

The objectives of this study were to investigate the long-term results of T1a, T1b and T1c Japanese invasive breast cancer patients defined by the UICC classification. The subjects were T1a (38), T1b (256) and T1c (1405) Japanese invasive breast cancer patients. Ten- and 20-year disease-free survival (DFS) and overall survival (OS) rates were analyzed by the UICC T1 subgroups (T1a, T1b, T1c). At 10 years, the respective DFS and OS rates of T1a, T1b and T1c patients were 91.9 and 91.9%, 86.1 and 86.8% and 82.4 and 83.9%, respectively. At 20 years, the respective DFS and OS rates of T1a, T1b and T1c patients were 70.7 and 70.7%, 76.7 and 76.7% and 69.1 and 70.1%. The differences of DFS and OS between T1a and T1c patients were not statistically significant. The DFS of patients with T1c breast carcinoma showed a statistically significant difference from that of T1b patients (p = 0.03). The validation of the T1 subgroup classification in Japanese breast cancer patients was confirmed, particularly for the T1c subgroup.

FOOTNOTES

+ For reprints and all correspondence: Takashi Fukutomi, Department of Surgical Oncology, National Cancer Center Hospital, 1–1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan. E-mail: tfukutom@gan2.ncc.go.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
E. O. Hanrahan, A. M. Gonzalez-Angulo, S. H. Giordano, R. Rouzier, K. R. Broglio, G. N. Hortobagyi, and V. Valero
Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma
J. Clin. Oncol., November 1, 2007; 25(31): 4952 - 4960.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. O. Hanrahan, V. Valero, A. M. Gonzalez-Angulo, and G. N. Hortobagyi
Prognosis and Management of Patients With Node-Negative Invasive Breast Carcinoma That Is 1 cm or Smaller in Size (stage 1; T1a,bN0M0): A Review of the Literature
J. Clin. Oncol., May 1, 2006; 24(13): 2113 - 2122.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.